BioVie Inc. Announces Proposed Public Offering
CARSON CITY, Nev., Sept. 23, 2024 ( GLOBE NEWSWIRE ) -- BioVie Inc. ( NASDAQ: BIVI ) ( "BioVie" or the "Company" ) , a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that it ...
| Ticker |
Sentiment |
Impact |
|
BIVI
|
Somewhat Bullish
|
30 %
|
|
STT
|
Neutral
|
4 %
|
